Anavex Life Sciences Corp (AVXL)
9.035
+0.56
(+6.61%)
USD |
NASDAQ |
Nov 21, 16:00
9.035
0.00 (0.00%)
After-Hours: 16:23
Anavex Life Sciences Price to Book Value: 5.903 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.537 |
| November 19, 2024 | 5.384 |
| November 18, 2024 | 4.868 |
| November 15, 2024 | 4.864 |
| November 14, 2024 | 5.247 |
| November 13, 2024 | 5.808 |
| November 12, 2024 | 5.893 |
| November 11, 2024 | 5.978 |
| November 08, 2024 | 6.037 |
| November 07, 2024 | 4.988 |
| November 06, 2024 | 5.090 |
| November 05, 2024 | 5.031 |
| November 04, 2024 | 4.770 |
| November 01, 2024 | 4.466 |
| October 31, 2024 | 4.325 |
| October 30, 2024 | 3.731 |
| October 29, 2024 | 3.734 |
| October 28, 2024 | 3.776 |
| October 25, 2024 | 3.424 |
| October 24, 2024 | 3.482 |
| October 23, 2024 | 3.522 |
| October 22, 2024 | 3.685 |
| October 21, 2024 | 3.561 |
| October 18, 2024 | 3.692 |
| October 17, 2024 | 3.597 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.610 |
| October 15, 2024 | 3.522 |
| October 14, 2024 | 3.535 |
| October 11, 2024 | 3.515 |
| October 10, 2024 | 3.339 |
| October 09, 2024 | 3.352 |
| October 08, 2024 | 3.424 |
| October 07, 2024 | 3.509 |
| October 04, 2024 | 3.656 |
| October 03, 2024 | 3.659 |
| October 02, 2024 | 3.695 |
| October 01, 2024 | 3.554 |
| September 30, 2024 | 3.711 |
| September 27, 2024 | 3.711 |
| September 26, 2024 | 3.705 |
| September 25, 2024 | 3.561 |
| September 24, 2024 | 3.633 |
| September 23, 2024 | 3.587 |
| September 20, 2024 | 3.685 |
| September 19, 2024 | 3.763 |
| September 18, 2024 | 3.594 |
| September 17, 2024 | 3.567 |
| September 16, 2024 | 3.724 |
| September 13, 2024 | 3.469 |
| September 12, 2024 | 3.404 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.100
Minimum
Apr 25 2024
27.57
Maximum
Jun 28 2021
7.221
Average
6.033
Median
Oct 06 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.223 |
Price to Book Value Related Metrics
| Price | 9.035 |
| Earnings Yield | -5.64% |
| Market Cap | 766.13M |